Herb-Drug Interactions

Which herbs and supplements interact with common medications?

St John's wort and grapefruit probably change blood levels of many drugs; licorice and kava have narrower risks, and ginkgo's bleeding risk is unproven.

Yes, some herbs change how medicines work. St John's wort is the clearest case: in trials it lowered blood levels of more than two dozen drugs, including birth-control pills, HIV drugs and warfarin1,3,4,5. Grapefruit does the opposite for others, raising levels of drugs such as simvastatin2. Licorice and kava carry narrower risks. Evidence that ginkgo causes bleeding is weak8. Tell your pharmacist everything you take.

What you can do

  • Show your pharmacist everything you take before starting a herb: in clinical trials St John's wort alone lowered the levels of more than two dozen drugs1.
  • If a medicine's label warns about grapefruit, avoid the fruit and its juice; in one study the juice raised simvastatin exposure 16-fold2.
  • Use our Interaction Checker as a first screen only; it covers a limited list, so no warning there is not clearance.

Be careful if

  • On birth control, HIV, transplant, blood-thinner or antidepressant medicines, avoid St John's wort unless your prescriber agrees: it lowered contraceptive exposure, cut indinavir over 50% and blunted warfarin's effect3,4,5.
  • On diuretics, digoxin or blood-pressure medicines? Avoid black licorice and licorice supplements, which can cause low potassium, high blood pressure and heart-rhythm problems6.
  • Liver disease, heavy alcohol use or liver-toxic medicines? Avoid kava; rare but serious liver injury has been reported, mostly with overdose, long use and other medicines7.
How it works What it does in your body, in plain words 2 min

Most herb-drug problems come from the same few routes. Some herbs switch on gut and liver enzymes and transporters that clear drugs, so drug levels fall. St John's wort does this through CYP enzyme and P-glycoprotein induction1. Others block those enzymes. Grapefruit furanocoumarins inhibit CYP3A4 in the intestine, so more of a drug gets into the blood9. A third group adds to a drug's own effect or side effects, such as licorice with corticosteroids10.

Herb by herb

  • St John's wort (strongest evidence). It reduced exposure to contraceptive hormones by 13 to 15 percent, with more breakthrough bleeding and signs of ovulation3. It cut the HIV drug indinavir's exposure by 57 percent4 and warfarin's anticoagulant effect5. It also lowered cyclosporine, tacrolimus, digoxin and statin levels, and with SSRIs it has been linked to mild serotonin syndrome1,10. See St John's wort.
  • Grapefruit. It affects calcium-channel blockers, immunosuppressants, antihistamines and statins, but the size of the effect depends on the product, the amount, and the person9,2. See grapefruit.
  • Licorice. Regularly eating large amounts of licorice can cause high blood pressure and low potassium, sometimes with arrhythmias6. See licorice root.
  • Kava. Rare liver injury has been reported, linked to overdose, long courses and co-medication7. See kava.
  • Ginkgo and ginger. In a controlled study, neither changed warfarin's effect11, and a meta-analysis found no clotting changes with ginkgo8. Case reports of bleeding exist but are hard to interpret1. See ginkgo.
  • Ginseng. It did not change warfarin levels or effect in a volunteer trial, though case reports suggest possible interactions5,1.

How to protect yourself. Keep one up-to-date list of every prescription, over-the-counter drug and supplement, and show it to your pharmacist at each refill. Never stop a prescription yourself. Our Interaction Checker can flag obvious conflicts, but it is not a clinical screen.

The evidence The studies, what they found, and how much to trust them 4 min · 12 sources

The overall picture

Izzo and Ernst reviewed seven popular herbs (ginkgo, St John's wort, ginseng, garlic, echinacea, saw palmetto and kava) and found 128 case reports or series and 80 clinical trials. Trials showed that St John's wort reduced plasma levels of 27 drugs or drug classes, including warfarin, digoxin, simvastatin, ciclosporin, tacrolimus, oral contraceptives, indinavir and methadone. Ginkgo lowered omeprazole, ritonavir and tolbutamide levels, and no interactions were reported for saw palmetto. The authors concluded that the significance of many interactions is uncertain, but several, particularly with St John's wort, may have serious consequences1. A review of herb-warfarin evidence rated nine of 38 herbs as major-severity interactions yet judged only four of the 38 as highly probable and 21 as doubtful, a reminder of how thin much of the evidence is12. An earlier review warned that many reports are sketchy and lack analysis of the suspect product10.

St John's wort

Murphy and colleagues gave 16 healthy women a low-dose pill and placebo for two cycles, then added St John's wort 300 mg three times daily for two cycles. Contraceptive exposure fell 13 to 15 percent, breakthrough bleeding increased, and there was evidence of follicle growth and probable ovulation. The study was small and single-blind and did not measure pregnancy3. Piscitelli's letter reported that St John's wort cut indinavir's area under the curve by a mean of 57% and the trough level by 81% in healthy volunteers, a drop large enough to risk treatment failure and drug resistance4. Jiang and colleagues gave 12 healthy men a single warfarin dose alone or after 14 days of St John's wort in a randomized crossover. The herb raised S-warfarin clearance (ratio 1.29, 90% CI 1.16 to 1.46) and lowered the INR area under the curve (ratio 0.79, 0.70 to 0.95)5.

Grapefruit

In a randomized crossover, 10 volunteers took double-strength grapefruit juice or water for two days, then 60 mg of simvastatin. The juice raised simvastatin's peak concentration about 9-fold and its area under the curve 16-fold, probably by blocking first-pass CYP3A4 metabolism in the small intestine. The authors advised avoiding large amounts or reducing the dose2. A review lists calcium-channel blockers, immunosuppressants and antihistamines among the affected drug classes and stresses the variability between products and people9. Note that this study used repeated glasses of double-strength juice, more than a typical breakfast glass.

Licorice and kava

A review of 104 case reports of licorice toxicity found pseudo-hyperaldosteronism with hypertension and low potassium as the typical picture, occasionally with arrhythmias, paralysis or rhabdomyolysis; toxicity often required hospital care but mortality was low6. Licorice has also been reported to potentiate corticosteroids10. Because low potassium is a recognized risk for digoxin toxicity and for some heart-rhythm problems, a hazard with digoxin or potassium-wasting diuretics is plausible, but we found no trial testing licorice with those drugs. For kava, a structured causality review of 14 patients with liver disease rated the link highly probable in one, probable in four and possible in nine. Risk factors included overdose, prolonged use and co-medication, and poor raw-material quality may contribute7.

Bleeding herbs: where the evidence is weak

Jiang and colleagues found that ginkgo and ginger, at recommended doses for a week before warfarin, did not change S-warfarin clearance (ginkgo ratio 1.05, 90% CI 0.98 to 1.21) or the INR area under the curve (ginkgo 0.93, 0.81 to 1.05; ginger 1.01, 0.93 to 1.15) in 12 healthy men11. A meta-analysis of 18 randomized trials (1,985 adults) found no effect of standardized ginkgo extract on platelet aggregation or prothrombin time, so it indicated no higher bleeding risk8. These are surrogate measures in mostly short trials, not bleeding events in anticoagulated patients, and case reports persist1. Reasonable caution is not the same as proof.

Limits of this evidence

Most data come from small volunteer studies with single drug doses, from case reports, and from products of unknown quality. Few studies follow patients on real regimens, and almost none compare brands.

Bottom line (confidence 4 of 5). St John's wort and grapefruit reliably alter drug levels and can matter clinically. Licorice and kava carry real but narrower risks. Ginkgo's bleeding risk is unproven. Always tell your pharmacist about everything you take.

  1. Interactions between herbal medicines and prescribed drugs: an updated systematic review. Izzo AA, Ernst E. Drugs, 2009. PubMed 19719333
  2. Grapefruit juice-simvastatin interaction: effect on serum concentrations of simvastatin, simvastatin acid, and HMG-CoA reductase inhibitors. Lilja JJ, Kivistö KT, Neuvonen PJ. Clin Pharmacol Ther, 1998. PubMed 9834039
  3. Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding. Murphy PA, Kern SE, Stanczyk FZ, et al.. Contraception, 2005. PubMed 15914127
  4. Indinavir concentrations and St John's wort. Piscitelli SC, Burstein AH, Chaitt D, et al.. Lancet, 2000. PubMed 10683007
  5. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Jiang X, Williams KM, Liauw WS, et al.. Br J Clin Pharmacol, 2004. PubMed 15089812
  6. Liquorice Toxicity: A Comprehensive Narrative Review. Ceccuzzi G, Rapino A, Perna B, et al.. Nutrients, 2023. PubMed 37764649
  7. Kava hepatotoxicity--a clinical review. Teschke R. Ann Hepatol, 2010. PubMed 20720265
  8. Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Kellermann AJ, Kloft C. Pharmacotherapy, 2011. PubMed 21923430
  9. Grapefruit-drug interactions. Seden K, Dickinson L, Khoo S, et al.. Drugs, 2010. PubMed 21142260
  10. Herb-drug interactions. Fugh-Berman A. Lancet, 2000. PubMed 10675182
  11. Effect of ginkgo and ginger on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Jiang X, Williams KM, Liauw WS, et al.. Br J Clin Pharmacol, 2005. PubMed 15801937
  12. Updates on the clinical evidenced herb-warfarin interactions. Ge B, Zhang Z, Zuo Z. Evid Based Complement Alternat Med, 2014. PubMed 24790635

Every change to this page is tracked in version control. View edit history. If you have conflicting research, we want to hear about it.

Spotted something wrong or out of date? Suggest a change.

Weekly research digest

New topics and updated research, once a week when there's something new. How it works